Evolving Early Outcomes After Transcatheter Aortic Valve Replacement in Asian Patients: Temporal Trends From the OCEAN-TAVI Registry

IF 3.4 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
Structural Heart Pub Date : 2026-08-01 Epub Date: 2026-05-14 DOI:10.1016/j.shj.2026.100851
Hirofumi Hioki MD, Masanori Yamamoto MD, Tetsuro Shimura MD, Shinichi Shirai MD, Yohei Ohno MD, Fumiaki Yashima MD, Toru Naganuma MD, Yusuke Watanabe MD, Futoshi Yamanaka MD, Gaku Nakazawa MD, Masahiko Noguchi MD, Masaki Izumo MD, Masahiko Asami MD, Hidetaka Nishina MD, Yasushi Fuku MD, Daisuke Hachinohe MD, Kenji Nishioka MD, Toshiaki Otsuka MD, Kentaro Hayashida MD, OCEAN-TAVI Investigators
{"title":"Evolving Early Outcomes After Transcatheter Aortic Valve Replacement in Asian Patients: Temporal Trends From the OCEAN-TAVI Registry","authors":"Hirofumi Hioki MD,&nbsp;Masanori Yamamoto MD,&nbsp;Tetsuro Shimura MD,&nbsp;Shinichi Shirai MD,&nbsp;Yohei Ohno MD,&nbsp;Fumiaki Yashima MD,&nbsp;Toru Naganuma MD,&nbsp;Yusuke Watanabe MD,&nbsp;Futoshi Yamanaka MD,&nbsp;Gaku Nakazawa MD,&nbsp;Masahiko Noguchi MD,&nbsp;Masaki Izumo MD,&nbsp;Masahiko Asami MD,&nbsp;Hidetaka Nishina MD,&nbsp;Yasushi Fuku MD,&nbsp;Daisuke Hachinohe MD,&nbsp;Kenji Nishioka MD,&nbsp;Toshiaki Otsuka MD,&nbsp;Kentaro Hayashida MD,&nbsp;OCEAN-TAVI Investigators","doi":"10.1016/j.shj.2026.100851","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>As transcatheter aortic valve replacement (TAVR) has expanded across a broad range of surgical risk profiles, evaluating temporal changes in outcomes has become increasingly important, particularly in the Asian population where patient characteristics differ from those of the Western population. The aim of the study was to evaluate the temporal trends in short-term outcomes after TAVR over the past decade in a large Asian multicenter registry.</div></div><div><h3>Methods</h3><div>This retrospective multicenter registry included 13,245 patients who underwent TAVR at 18 centers from 2013 to 2023. Temporal trends in 30-day mortality, 30-day stroke, and 30-day pacemaker implantation (PMI), and paravalvular leakage (PVL) ≥ mild at discharge were assessed using multiple imputation and center-clustered generalized estimating equations. The effect modification by age and surgical risk was prespecified.</div></div><div><h3>Results</h3><div>The median age was 85 years, and the median Society of Thoracic Surgeons (STS) score was 5.6%. Over time, patient profiles shifted toward lower risk, and procedures became less invasive. Consistent across age and Society of Thoracic Surgeons risk strata, the overall risk-adjusted 30-day mortality remained low and did not change significantly over time. In contrast, the risk-adjusted PMI and PVL ≥ mild declined significantly over time, particularly in TAVR using balloon-expandable valves (BEVs). The risk-adjusted incidence of 30-day stroke did not change significantly.</div></div><div><h3>Conclusions</h3><div>Early mortality after TAVR in the Asian cohort has remained consistently low over the past decade. Although device-related complications such as PMI and PVL improved substantially, periprocedural stroke remained as a key unmet clinical challenge.</div></div>","PeriodicalId":36053,"journal":{"name":"Structural Heart","volume":"10 8","pages":"Article 100851"},"PeriodicalIF":3.4000,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Structural Heart","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2474870626000606","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/5/14 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background

As transcatheter aortic valve replacement (TAVR) has expanded across a broad range of surgical risk profiles, evaluating temporal changes in outcomes has become increasingly important, particularly in the Asian population where patient characteristics differ from those of the Western population. The aim of the study was to evaluate the temporal trends in short-term outcomes after TAVR over the past decade in a large Asian multicenter registry.

Methods

This retrospective multicenter registry included 13,245 patients who underwent TAVR at 18 centers from 2013 to 2023. Temporal trends in 30-day mortality, 30-day stroke, and 30-day pacemaker implantation (PMI), and paravalvular leakage (PVL) ≥ mild at discharge were assessed using multiple imputation and center-clustered generalized estimating equations. The effect modification by age and surgical risk was prespecified.

Results

The median age was 85 years, and the median Society of Thoracic Surgeons (STS) score was 5.6%. Over time, patient profiles shifted toward lower risk, and procedures became less invasive. Consistent across age and Society of Thoracic Surgeons risk strata, the overall risk-adjusted 30-day mortality remained low and did not change significantly over time. In contrast, the risk-adjusted PMI and PVL ≥ mild declined significantly over time, particularly in TAVR using balloon-expandable valves (BEVs). The risk-adjusted incidence of 30-day stroke did not change significantly.

Conclusions

Early mortality after TAVR in the Asian cohort has remained consistently low over the past decade. Although device-related complications such as PMI and PVL improved substantially, periprocedural stroke remained as a key unmet clinical challenge.
亚洲患者经导管主动脉瓣置换术后早期预后的演变:来自OCEAN-TAVI登记的时间趋势
背景:随着经导管主动脉瓣置换术(TAVR)在手术风险方面的广泛应用,评估结果的时间变化变得越来越重要,特别是在患者特征与西方人群不同的亚洲人群中。本研究的目的是在一个大型亚洲多中心注册中心中评估过去十年TAVR术后短期结果的时间趋势。方法该回顾性多中心登记包括2013年至2023年在18个中心接受TAVR的13,245例患者。使用多重输入和中心聚类广义估计方程评估30天死亡率、30天卒中、30天起搏器植入(PMI)和出院时瓣旁漏(PVL)≥轻度的时间趋势。预先规定了年龄和手术风险对效果的影响。结果患者中位年龄为85岁,胸外科学会(STS)评分中位为5.6%。随着时间的推移,患者的情况逐渐向低风险转变,手术的侵入性也越来越小。在不同年龄和胸外科学会的风险层中,总体风险调整后的30天死亡率仍然很低,并且随着时间的推移没有显著变化。相比之下,风险调整PMI和PVL≥轻度随时间显著下降,特别是在使用球囊膨胀阀(bev)的TAVR中。经风险调整后的30天卒中发生率没有显著变化。结论:在过去十年中,亚洲人群TAVR后的早期死亡率一直保持在较低水平。尽管器械相关的并发症如PMI和PVL有了很大的改善,但术中卒中仍然是一个关键的临床挑战。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Structural Heart
Structural Heart Medicine-Cardiology and Cardiovascular Medicine
CiteScore
1.60
自引率
0.00%
发文量
81
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书